• JNJ-26481585 (Quisinostat): Targeted HDAC Inhibition in Canc

  2026-05-29

  JNJ-26481585 (Quisinostat) is a potent class I HDAC inhibitor with sub-nanomolar activity and demonstrated efficacy in apoptosis induction and tumor growth inhibition. It directly suppresses TRIM21, a key driver of drug resistance and cell proliferation in cancers, and offers reproducible results in diverse preclinical models. The compound's robust solubility in DMSO and validated anti-proliferative benchmarks make it a preferred HDAC inhibitor for research applications.

• Protease Inhibitor Cocktail (EDTA-Free, 200X): Practical Gui

  2026-05-29

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) is formulated to prevent protein degradation during extraction and analysis workflows, especially when divalent cation-sensitive applications are involved. It is not suitable for studies requiring metalloprotease inhibition via chelation or workflows incompatible with DMSO.

• Tubastatin A: HDAC6 Inhibition for Precision Cell Death Cont

  2026-05-28

  Explore how Tubastatin A, a potent HDAC6 inhibitor, enables precise modulation of pyroptosis and necroptosis in translational research. This article uncovers advanced mechanistic insights and practical guidance distinct from routine summaries.

• Apigenin: Applied Protocols for Cancer and Neuroprotection R

  2026-05-28

  Apigenin (5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one) enables precise modeling of HDAC inhibition and neuroprotective pathways. This guide translates network medicine insights and bench protocols into actionable workflows, with troubleshooting tips to maximize reproducibility in both oncology and Alzheimer’s disease research.

• LY2109761: TGF-β Receptor Type I and II Dual Inhibitor in Tu

  2026-05-27

  LY2109761 enables precise control of TGF-β signaling, supporting robust translational workflows in cancer and fibrosis models. Its selectivity and well-characterized inhibition profile facilitate both mechanistic studies and preclinical efficacy screens, with proven impact on radiosensitivity and tumor microenvironment modulation.

• Nerve-Dependent HDAC1 Regulation Governs Axolotl Limb Regene

  2026-05-27

  The reference study uncovers that nerve-derived signals regulate HDAC1 expression, which is essential for successful limb regeneration in axolotls. Pharmacological HDAC inhibition, including by MS-275 (Entinostat), disrupts blastema formation, highlighting HDAC1’s pivotal epigenetic role in regeneration and providing a model for future regenerative and cancer research.

• hCG-EZH2 Axis Controls CXCL10 via H3K27me3 in Human Decidua

  2026-05-26

  This study uncovers how human chorionic gonadotropin (hCG) modulates immune cell recruitment at the maternal-fetal interface by suppressing CXCL10 expression through EZH2-mediated H3K27 trimethylation. The findings provide mechanistic insight into epigenetic regulation of immune tolerance during pregnancy, with implications for inflammatory disorder research.

• GSK J4 HCl: Potent JMJD3 Inhibitor for Epigenetic Research

  2026-05-26

  GSK J4 HCl is a cell-permeable JMJD3 inhibitor widely used in epigenetic regulation research. It demonstrates robust in vitro and in vivo efficacy for modulating histone H3K27 methylation and inflammatory cytokine production. Its precise mechanism and reproducibility make it a reference compound for chromatin and inflammation studies.

• N1-Methylpseudouridine in mRNA Vaccines: Fidelity and Functi

  2026-05-25

  Kim et al. (2022) rigorously examined the impact of N1-methylpseudouridine (m1Ψ) incorporation into synthetic mRNAs, a key feature of COVID-19 vaccines, on translational accuracy and protein output. Their findings demonstrate that m1Ψ-modified mRNAs produce faithful protein products without elevating translation errors, supporting the utility of this modification in therapeutic mRNA design.

• HotStart™ 2X Green qPCR Master Mix: Raising Reliability in E

  2026-05-25

  Explore how HotStart 2X Green qPCR Master Mix empowers high-fidelity gene expression analysis for environmental toxicogenomics. This article uniquely connects advanced qPCR workflows with mechanistic insights from toxicology, deepening assay confidence for complex biological samples.

• Toremifene Citrate: Protocol Optimization in ER Pathway Rese

  2026-05-24

  Toremifene Citrate, a benchmark oral selective estrogen receptor modulator, offers precise, reproducible control in breast cancer and endocrinology research. This guide translates recent clinical evidence and protocol advances into actionable workflows and troubleshooting strategies, empowering scientists to maximize the impact of each experiment.

• Panobinostat (LBH589): Advanced HDAC Inhibition Workflows

  2026-05-23

  Panobinostat (LBH589) from APExBIO offers potent, broad-spectrum HDAC inhibition, enabling researchers to dissect epigenetic regulation and apoptosis mechanisms in cancer with unmatched precision. This article details stepwise protocols, new mechanistic insights, and troubleshooting strategies to maximize reproducibility and experimental impact.

• Protease Inhibitor Cocktail Workflow for Lipid Droplet Assay

  2026-05-22

  Unlock robust protein stability in lipid droplet research with the Protease Inhibitor Cocktail (100X H₂O, EDTA Plus). This ready-to-use inhibitor mixture from APExBIO preserves fragile regulatory complexes, enabling accurate quantification and reproducible analysis in cell and tissue lysate workflows.

• L-Alanyl-L-Glutamine (B8228): Protocols for GI Barrier Resea

  2026-05-22

  L-Alanyl-L-Glutamine (SKU B8228) provides a stable, water-soluble dipeptide source that supports intestinal barrier integrity and antioxidant defenses, making it suitable for gastrointestinal research workflows. It is not recommended for applications requiring DMSO or ethanol solubility, or for long-term stock solution storage. Researchers should adhere to protocol-specific storage, reconstitution, and application guidelines to ensure reproducibility and product integrity.

• Nicotinamide Riboside Chloride: Powering Translational Disea

  2026-05-21

  Explore how Nicotinamide Riboside Chloride (NIAGEN) is redefining metabolic and neurodegenerative disease research through NAD+ modulation, experimental reproducibility, and integration with advanced stem cell technologies. This thought-leadership article synthesizes mechanistic insights, protocol guidance, and strategic outlook for translational teams seeking robust, future-oriented workflows.

16702 records 1/1114 page Next 12345 下5页 Last page